Loading…
Loading…
KHNP is KEPCO's nuclear-and-hydro generation subsidiary, operating all of South Korea's nuclear reactors (Kori, Hanbit, Hanul, Wolsong/Saeul) plus conventional hydro and pumped-storage plants — together roughly a third of national generation.
Named counterparties identified by open-source research and written only where a primary source states the relationship — never inferred from sector or co-mention. 1 supplier. This is a partial view: it covers the relationships we could evidence, not the company's full supply base.
Urenco: signed a new long-term enrichment-services supply contract with KHNP on 22 March 2024 in Brussels, continuing a relationship 'since 1993' and confirming Urenco as 'a major supplier for them well into the next decade'; enrichment plant not specified.
Scope. Absence of a counterparty here is not evidence that none exists — most commercial sourcing is confidential and never becomes public. Rows without a share figure mean no share was disclosed, not that the relationship is small.
Another tracked dossier names this company as a counterparty in its own sourced disclosure — this platform never wrote these rows on this company's own page, they are read here inverted from the dossier that disclosed them. This is a partial view: 990 additional named-counterparty rows across the corpus could not be matched to a tracked dossier by name at all (mostly non-Latin legal names), so the true count is higher than what renders here.
Urenco: signed a new long-term enrichment-services supply contract with KHNP on 22 March 2024 in Brussels, continuing a relationship 'since 1993' and confirming Urenco as 'a major supplier for them well into the next decade'; enrichment plant not specified.
Scope. This section is inverted evidence: each linked dossier wrote the original row about itself, describing its own relationship to this company. It is never a claim this company itself disclosed. Absence here is not evidence of no relationship — most of the corpus has no named-counterparty block at all yet.
Every exposure is read as a buyer dependency; the top 1 are its binding chokepoints.
No actions in the register have named or swept this company in the last 24 months.